The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Inclusion Criteria

• •Willing and able to give informed consent for participation in the study.
• •Male or female participants, aged 18 years or older as of signing the informed consent form.
• •Receiving SoC medications (penicillamine, trientine, zinc, or copper chelators with zinc) for the treatment of WD at the time of enrollment and for no more than 60 months prior to enrollment.
• •Able to understand and willing to comply with study procedures and requirements, as judged by the Investigator.
• •Established diagnosis of WD.
• •Adequate venous access to allow for collection of blood samples.